All Participants | |||||
---|---|---|---|---|---|
Variable | Baseline n = 18 | 6 months n = 16 | 12 months n = 17 | Baseline vs after 6 months p-value | Baseline vs after 12 months p-value |
Total cholesterol (mmol/l) | 4.11(0.62) | 4.16(0.68) | 4.32(0.67) | 0.17 | 0.036 |
Total triglycerides (mmol/l) | 0.72(0.21) | 0.91(0.30) | 0.72(0.22) | 0.015 | 0.98 |
LDL-cholesterol (mmol/l) | 2.29(0.54) | 2.29(0.63) | 2.55(0.67) | 0.28 | 0.006 |
HDL-cholesterol (mmol/l) | 1.51(0.41) | 1.46(0.46) | 1.43(0.46) | 0.25 | 0.22 |
Apolipoprotein A1 (g/L) | 1.55(0.40) | 1.26(0.31) | 1.24(0.27) | 0.004 | 0.003 |
Apolipoprotein B (g/L) | 0.73(0.16) | 0.79(0.18) | 0.80(0.24) | 0.86 | 0.49 |
ALP (μkat/l) | 0.97(0.50) | 1.16(0.86) | 1.04(0.82) | 0.12 | 0.57 |
ASAT (μkat/l) | 0.48(0.21) | 0.43(0.14) | 0.45(0.25) | 0.31 | 0.64 |
ALAT (μkat/l) | 0.37(0.20) | 0.43()0.37 | 0.42(0.36) | 0.34 | 0.48 |
Fasting plasma glucose (mmol/l) | 4.7(0.35) | 4.8(0.29) | 4.8(0.37) | 0.45 | 0.75 |
Fasting insulin (pmol/L) | 29.9(13.8) | 37.9(27) | 35(16.5) | 0.16 | 0.23 |
HOMA-IR | 0.9(0.4) | 1.2(0.8) | 1.1(0.5) | 0.15 | 0.39 |